{"public_id":"cl_8649c323fc538e18e129e9d37a8bf55d","status":"active","superseded_by_public_id":null,"corpus_id":251998037,"text":"Apatinib combined with homoharringtonine markedly inhibits proliferation, reduces colony-forming capacity, and induces apoptosis and cell cycle arrest in acute myeloid leukemia cells.","confidence":0.98,"paper":{"corpus_id":251998037,"title":"Synergistic Lethality Effects of Apatinib and Homoharringtonine in Acute Myeloid Leukemia","url":"https://sah.borca.ai/papers/251998037"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.98,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_77007e36373ae4bb6a07ce476802c3a2","name":"apoptosis","description":"Programmed cell death measured in the treated leukemia cells.","types":["cellular process"],"url":"https://sah.borca.ai/concepts/co_77007e36373ae4bb6a07ce476802c3a2"},{"public_id":"co_9abfe4092a8fcff30aa02768938ef416","name":"cell cycle arrest","description":"A blockage or halt in cell-cycle progression in the treated cells.","types":["cellular process"],"url":"https://sah.borca.ai/concepts/co_9abfe4092a8fcff30aa02768938ef416"},{"public_id":"co_b84ca96c8c70824a9413d8b28adc169f","name":"colony-forming capacity","description":"The ability of leukemia cells to form colonies in culture.","types":["cellular phenotype"],"url":"https://sah.borca.ai/concepts/co_b84ca96c8c70824a9413d8b28adc169f"},{"public_id":"co_bb2a7dd18cc7bf3806c0c3d895638f47","name":"cell proliferation","description":"The growth and increase in number of leukemia cells.","types":["cellular process"],"url":"https://sah.borca.ai/concepts/co_bb2a7dd18cc7bf3806c0c3d895638f47"},{"public_id":"co_c8a9a2c1c9a7ade3a48ac179d1d425cd","name":"apatinib combined with homoharringtonine","description":"The drug combination of apatinib and homoharringtonine tested for antileukemia activity.","types":["combination therapy"],"url":"https://sah.borca.ai/concepts/co_c8a9a2c1c9a7ade3a48ac179d1d425cd"},{"public_id":"co_fe35e2dbe624d8e44cdcd7f41cfca364","name":"acute myeloid leukemia","description":"A malignant hematologic cancer of myeloid precursor cells.","types":["disease"],"url":"https://sah.borca.ai/concepts/co_fe35e2dbe624d8e44cdcd7f41cfca364"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_8649c323fc538e18e129e9d37a8bf55d"}